Apogee Therapeutics, Inc.
Total Trades
37
Buys
2
Sells
30
Largest Trade
$1M+
Insiders
5
Institutional Funds
156
Inst. Value
$1M+
Activist Filings
28
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Henderson Jane | CFO | SELL | $100K–$500K | 2K | $70.22 | Mar 5, 2026 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $1M+ | 20K | $63.35 | Feb 14, 2026 |
| Dambkowski Carl | Chief Medical Offi… | EXERCISE | $50K–$100K | 4K | $22.86 | Feb 5, 2026 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 6K | $65.79 | Feb 5, 2026 |
| Henderson Jane | CFO | SELL | $100K–$500K | 2K | $65.81 | Feb 5, 2026 |
| Fairmount Funds Management LLC | Director | SELL | $1M+ | 1.8M | $76.30 | Jan 23, 2026 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $1M+ | 20K | $81.11 | Jan 17, 2026 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $1M+ | 19K | $77.84 | Jan 10, 2026 |
| Dambkowski Carl | Chief Medical Offi… | EXERCISE | $100K–$500K | 14K | $22.86 | Jan 10, 2026 |
| Henderson Jane | CFO | SELL | $500K+ | 8K | $76.14 | Jan 7, 2026 |
| Henderson Jane | CFO | SELL | $100K–$500K | 2K | $80.00 | Dec 24, 2025 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $1M+ | 20K | $75.38 | Dec 13, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $500K+ | 11K | $75.00 | Dec 6, 2025 |
| Henderson Jane | CFO | SELL | $100K–$500K | 2K | $75.00 | Dec 6, 2025 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $1M+ | 40K | $75.01 | Dec 6, 2025 |
| Henderson Jane | CFO | SELL | $100K–$500K | 2K | $70.00 | Nov 29, 2025 |
| Henderson Jane | CFO | SELL | $100K–$500K | 2K | $65.00 | Nov 15, 2025 |
| Henderson Jane | CFO | SELL | $50K–$100K | 1K | $60.00 | Nov 14, 2025 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $1M+ | 20K | $63.01 | Nov 14, 2025 |
| Dambkowski Carl | Chief Medical Offi… | EXERCISE | $100K–$500K | 8K | $22.86 | Nov 8, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $500K+ | 11K | $55.07 | Nov 8, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 3K | $37.87 | Sep 6, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 10K | $45.09 | Jul 4, 2025 |
| Dambkowski Carl | Chief Medical Offi… | EXERCISE | $100K–$500K | 7K | $22.86 | Jul 4, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 3K | $36.96 | Jun 7, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $50K–$100K | 3K | $35.75 | May 10, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 4K | $36.22 | Apr 5, 2025 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $500K+ | 15K | $48.85 | Jan 11, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 4K | $46.94 | Jan 4, 2025 |
| Dambkowski Carl | Chief Medical Offi… | EXERCISE | $15K–$50K | 1K | $22.86 | Jan 4, 2025 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 7K | $59.12 | Nov 9, 2024 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $500K+ | 15K | $59.22 | Nov 9, 2024 |
| Dambkowski Carl | Chief Medical Offi… | SELL | $100K–$500K | 7K | $56.26 | Oct 5, 2024 |
| HENDERSON MICHAEL THOMAS | CEO | SELL | $1M+ | 40K | $56.23 | Oct 5, 2024 |
| Henderson Jane | CFO | SELL | $100K–$500K | 6K | $48.26 | Aug 24, 2024 |
| Shah Nimish P | Director | BUY | $1M+ | 1.8M | $17.00 | Jul 18, 2023 |
| Fairmount Funds Management LLC | Director | BUY | $1M+ | 2.9M | $17.00 | Jul 18, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 156 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VR Adviser, LLC | 8.5M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 2.3M | $1M+ | SH |
| Fairmount Funds Management LLC | 2.0M | $1M+ | SH |
| STATE STREET CORP | 1.7M | $1M+ | SH |
| Affinity Asset Advisors, LLC | 1.2M | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 1.1M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 913K | $1M+ | SH |
| MERCER GLOBAL ADVISORS INC /ADV | 891K | $1M+ | SH |
| Remedium Capital Partners, LLC | 584K | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 579K | $1M+ | SH |
| BRAIDWELL LP | 575K | $1M+ | SH |
| Novo Holdings A/S | 570K | $1M+ | SH |
| Sofinnova Investments, Inc. | 535K | $1M+ | SH |
| First Turn Management, LLC | 475K | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 436K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 381K | $1M+ | SH |
| VANGUARD GROUP INC | 325K | $1M+ | SH |
| Pictet Asset Management Holding SA | 313K | $1M+ | SH |
| First Light Asset Management, LLC | 285K | $1M+ | SH |
| LOOMIS SAYLES & CO L P | 209K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Wellington Management Group LLP
SC 13G/A · Feb 10, 2026
8.7%
4.7M shares
SC 13G · Jan 30, 2026
5.2%
2.9M shares
Fairmount Funds Management LLC
SC 13D/A · Jan 23, 2026
9.8%
5.9M shares
DRIEHAUS CAPITAL MANAGEMENT LLC
SC 13G/A · Nov 14, 2025
4.7%
2.2M shares
Fairmount Funds Management LLC
SC 13D/A · Oct 14, 2025
9.8%
5.7M shares
SC 13G/A · Aug 6, 2025
15.0%
6.9M shares
Wellington Management Group LLP
SC 13G/A · Aug 5, 2025
10.6%
4.9M shares
Wellington Management Group LLP
SC 13G/A · Aug 5, 2025
8.3%
3.8M shares
SC 13G/A · Jul 16, 2025
5.5%
2.5M shares
Wellington Management Group LLP
SC 13G/A · May 12, 2025
11.9%
5.5M shares
SC 13G · Feb 14, 2025
6.0%
2.7M shares
SC 13G/A · Nov 14, 2024
3.4%
2.0M shares
DRIEHAUS CAPITAL MANAGEMENT LLC
SC 13G · Nov 14, 2024
5.6%
2.5M shares
SC 13G/A · Nov 14, 2024
2.2%
1.0M shares
SC 13G/A · Nov 12, 2024
16.7%
7.5M shares
SC 13G · Nov 8, 2024
6.6%
3.0M shares
SC 13G/A · Nov 5, 2024
4.9%
2.2M shares
SC 13G · Oct 22, 2024
6.6%
3.0M shares
Wellington Management Group LLP
SC 13G · Oct 4, 2024
10.7%
4.8M shares
Fairmount Funds Management LLC
SC 13D/A · Apr 1, 2024
10.0%
4.8M shares
SC 13G · Feb 14, 2024
5.3%
2.0M shares
SC 13G/A · Feb 14, 2024
6.3%
2.3M shares
Fairmount Funds Management LLC
SC 13D/A · Jan 31, 2024
10.0%
5.4M shares
SC 13G · Nov 3, 2023
5.2%
1.9M shares
SC 13G · Aug 10, 2023
12.1%
4.4M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13D · Jul 28, 2023
0.0%
3.9M shares
SC 13G · Jul 24, 2023
8.9%
3.0M shares
Fairmount Funds Management LLC
SC 13D · Jul 21, 2023
10.0%
3.8M shares